Delivery of Messenger RNA Using Poly(ethylene Imine)-poly(ethylene Glycol)-copolymer Blends for Polyplex Formation: Biophysical Characterization and in Vitro Transfection Properties
Overview
Affiliations
Nucleic acid based therapies have so far mainly been focused on plasmid DNA (pDNA), small interfering RNA (siRNA), antisense and immunostimulatory oligonucleotides. Messenger RNA (mRNA) was the subject of only a few studies. The objective of this investigation was the preparation of new composite polyplexes with mRNA consisting of poly(ethylene imine) (PEI) and poly(ethylene imine)-poly(ethylene glycol)-copolymers (PEI-PEG) as blends. These complexes were designed to increase the stability of mRNA, to improve transfection efficiency and to reduce cytotoxicity. Hydrodynamic diameters of the polyplexes were measured by dynamic light scattering, polyplex stability was analyzed by gel retardation assay and transfection efficiency of luciferase (Luc) encoding mRNA was evaluated under in vitro conditions. Most of the polyplexes generated showed small particle sizes <200 nm and positive zeta-potentials of +20 mV to +30 mV. Stable complexes were formed even at low nitrogen to phosphate ratios. Polyplexes with mRNA Luc and blends of low molecular weight PEI(5 kDa) and PEI(25k Da)-PEG(20 kDa)₁-block-copolymer showed protein expression as high as polyplexes with PEI(25 kDa). Moreover, luciferase expression was significantly higher than that obtained with one of the components alone. These results suggest that delivery systems for pulmonary application of mRNA merit further investigation under in vitro and in vivo conditions.
Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges.
Bai Z, Wan D, Lan T, Hong W, Dong H, Wei Y ACS Nano. 2024; 18(36):24650-24681.
PMID: 39185745 PMC: 11394369. DOI: 10.1021/acsnano.3c10797.
Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment.
Karim M, Haque S, Al-Busaidi H, Bakhtiar A, Tha K, Banaszak Holl M Arch Pharm Res. 2022; 45(12):865-893.
PMID: 36422795 PMC: 9686230. DOI: 10.1007/s12272-022-01418-x.
Recent Advances of Chitosan Formulations in Biomedical Applications.
Abourehab M, Pramanik S, Abdelgawad M, Abualsoud B, Kadi A, Javed Ansari M Int J Mol Sci. 2022; 23(18).
PMID: 36142887 PMC: 9504745. DOI: 10.3390/ijms231810975.
A facile methodology using quantum dot multiplex labels for tracking co-transfection.
Kretzmann J, Feng R, Munshi A, Ho D, Ranieri A, Massi M RSC Adv. 2022; 9(35):20053-20057.
PMID: 35514698 PMC: 9065570. DOI: 10.1039/c9ra03518d.
Chitosan as possible inhibitory agents and delivery systems in leukemia.
Zivarpour P, Hallajzadeh J, Asemi Z, Sadoughi F, Sharifi M Cancer Cell Int. 2021; 21(1):544.
PMID: 34663339 PMC: 8524827. DOI: 10.1186/s12935-021-02243-w.